News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Generex Biotechnology Corporation (GNBT) Signs Agreement With Cardinal Health (North Carolina) (CAH) For Generex Oral-lyn(TM) Manufacturing For Clinical Trials


6/22/2006 11:15:49 AM

TORONTO--(MARKET WIRE)--Jun 22, 2006 -- Generex Biotechnology Corporation (NasdaqSC:GNBT - News), a leader in the area of buccal drug delivery, announced today that it has entered into contractual arrangements with Cardinal Health, Inc. (NYSE:CAH - News), the leading provider of products and services supporting the health-care industry, to manufacture clinical trial batches of Generex Oral-lyn(TM), a proprietary oral insulin spray product.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES